Do We Need Worms to Promote Immune Health?

Clinical Reviews in Allergy and Immunology

Volumn 49, Issue 2, 2015, Pages 227-231

  Weinstock, Joel V ^a  

^a TUFTS MEDICAL CENTER   (United States)

Author keywords

Autoimmunity; C type lectin receptors; Dendritic cells; Helminths; Inflammatory bowel disease; Macrophage; Treg

Indexed keywords

CYTOKINE; ESTROGEN; VITAMIN D; PARASITE ANTIGEN;

ARTICLE; ASCARIS LUMBRICOIDES; ASTHMA; AUTOIMMUNE DISEASE; CYTOKINE PRODUCTION; DENDRITIC CELL; ENTEROBIUS VERMICULARIS; FOOD ALLERGY; HELIGMOSOMOIDES POLYGYRUS; HELMINTH; HUMAN; IMMUNITY; IMMUNOMODULATION; IMMUNOPATHOLOGY; IMMUNOREGULATION; INFLAMMATORY BOWEL DISEASE; INSULIN DEPENDENT DIABETES MELLITUS; INTESTINE FLORA; MACROPHAGE; MULTIPLE SCLEROSIS; MYCOBACTERIUM; NECATOR AMERICANUS; NONHUMAN; PROTECTION; REGULATORY T LYMPHOCYTE; STRONGYLE INFECTION; T LYMPHOCYTE ACTIVATION; TOXOCARA CANIS; ANIMAL; CLINICAL TRIAL (TOPIC); HYGIENE HYPOTHESIS; IMMUNE SYSTEM DISEASES; IMMUNOLOGY; METABOLISM; PARASITOLOGY; THERAPY WITH HELMINTHS;

ANIMALS; ANTIGENS, HELMINTH; CLINICAL TRIALS AS TOPIC; CYTOKINES; HELMINTHS; HUMANS; HYGIENE HYPOTHESIS; IMMUNE SYSTEM DISEASES; IMMUNOMODULATION; MACROPHAGES; T-LYMPHOCYTES, REGULATORY; THERAPY WITH HELMINTHS;

EID: 84944165332     PISSN: 10800549     EISSN: 15590267     Source Type: Journal    
DOI: 10.1007/s12016-014-8458-3     Document Type: Article

References (45)

1. Poinar G Jr, Boucot AJ (2006) Evidence of intestinal parasites of dinosaurs. Parasitol 133(Pt 2):245–9
2. Stoll NR (1947) This wormy world. J Parasitol 33:1–18
3. de Silva NR, Brooker S, Hotez PJ, Montresor A, Engels D, Savioli L (2003) Soil-transmitted helminth infections: updating the global picture. Trends Parasitol 19:547–551
4. Weinstock JV, Summers R, Elliott DE (2004) Helminths and harmony. Gut 53:7–9
5. Ascherio A, Munger KL, Lunemann JD (2012) The initiation and prevention of multiple sclerosis. [Review]. Nat Rev Neurol 8:602–612
6. Melcon MO, Melcon CM, Bartoloni L, Cristiano E, Duran JC, Grzesiuk AK, Fragoso YD, Brooks JB, Diaz V, Romero Garcia KM, Cabrera Gomez JA, Abad P, Islas MA, Gracia F, de Diaz Bedoya VF, Ruiz ME, Hackembruch JH, Oehninger C, Ketzoian CN, Soto A, Grupo Colaborativo Multicentrico para el Estudio de la Esclerosis Multiple en America Latina (2013) Towards establishing MS prevalence in Latin America and the Caribbean. Mult Scler 19:145–152
7. Molodecky NA, Soon IS, Rabi DM, Ghali WA, Ferris M, Chernoff G, Benchimol EI, Panaccione R, Ghosh S, Barkema HW, Kaplan GG (2012) Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterol 142:46–54
8. Egro FM (2013) Why is type 1 diabetes increasing? J Mol Endocrinol 51:R1–13
9. Eder W, Ege MJ, von Mutius E (2006) The asthma epidemic. N Engl J Med 355:2226–2235
10. Sicherer SH, Sampson HA (2014) Food allergy: epidemiology, pathogenesis, diagnosis, and treatment. J All Clin Immunol 133:291–307
11. Sonnenberg A, McCarty DJ, Jacobsen SJ (1991) Geographic variation of inflammatory bowel disease within the United States. Gastroenterol 100:143–149
12. Shivananda S, Lennard-Jones J, Logan R, Fear N, Price A, Carpenter L, van Blankenstein M (1996) Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). Gut 39:690–697
13. Koch-Henriksen N, Sorensen PS (2011) Why does the north–south gradient of incidence of multiple sclerosis seem to have disappeared on the northern hemisphere? J Neurol Sci 311:58–63
14. Carr I, Mayberry JF (1999) The effects of migration on ulcerative colitis: a three-year prospective study among Europeans and first- and second- generation South Asians in Leicester (1991–1994). Am J Gastroenterol 94:2918–2922
15. Jayanthi V, Probert CS, Pinder D, Wicks AC, Mayberry JF (1992) Epidemiology of Crohn’s disease in Indian migrants and the indigenous population in Leicestershire. Q J Med 82:125–138
16. Probert CS, Jayanthi V, Hughes AO, Thompson JR, Wicks AC, Mayberry JF (1993) Prevalence and family risk of ulcerative colitis and Crohn’s disease: an epidemiological study among Europeans and south Asians in Leicestershire. Gut 34:1547–1551
17. Handel AE, Giovannoni G, Ebers GC, Ramagopalan SV (2010) Environmental factors and their timing in adult-onset multiple sclerosis. Nat Rev Neurol 6:156–166
18. Molodecky NA, Soon IS, Rabi DM, Ghali WA, Ferris M, Chernoff G, Benchimol EI, Panaccione R, Ghosh S, Barkema HW, Kaplan GG (2012) Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. [Review]. Gastroenterol 142:46–54
19. Bach JF (2002) The effect of infections on susceptibility to autoimmune and allergic diseases. N Eng J Med 347(12):911–20
20. Yazdanbakhsh M, Kremsner PG, van Ree R (2002) Allergy, parasites, and the hygiene hypothesis. Science 296:490–494
21. Elliott DE, Urban JF Jr, Argo CK, Weinstock JV (2000) Does the failure to acquire helminthic parasites predispose to Crohn’s disease? FASEB J 14:1848–1855
22. Correale J, Farez MF (2011) The impact of environmental infections (parasites) on MS activity. Mult Scler 17:1162–1169
23. Kabeerdoss J, Pugazhendhi S, Subramanian V, Binder HJ, Ramakrishna BS (2011) Exposure to hookworms in patients with Crohn’s disease: a case–control study. Aliment Pharmacol Ther 34:923–930
24. van den Biggelaar AH, Rodrigues LC, van Ree R, van der Zee JS, Hoeksma-Kruize YC, Souverijn JH, Missinou MA, Borrmann S, Kremsner PG, Yazdanbakhsh M (2004) Long-term treatment of intestinal helminths increases mite skin-test reactivity in Gabonese schoolchildren. J Inf Dis 189:892–900
25. Correale J, Farez M (2007) Association between parasite infection and immune responses in multiple sclerosis. Ann Neurol 61:97–108
26. Correale J, Farez M (2009) Helminth antigens modulate immune responses in cells from multiple sclerosis patients through TLR2-dependent mechanisms. J Immunol 183(9):5999–6012
27. Fleming JO, Isaak A, Lee JE, Luzzio CC, Carrithers MD, Cook TD, Field AS, Boland J, Fabry Z (2011) Probiotic helminth administration in relapsing-remitting multiple sclerosis: a phase 1 study. Multiple Sclerosis J. 1–12
28. Scrivener S, Yemaneberhan H, Zebenigus M, Tilahun D, Girma S, Ali S, McElroy P, Custovic A, Woodcock A, Pritchard D, Venn A, Britton J (2001) Independent effects of intestinal parasite infection and domestic allergen exposure on risk of wheeze in Ethiopia: a nested case–control study. Lancet 358:1493–1499
29. Flohr C, Tuyen LN, Lewis S, Quinnell R, Minh TT, Liem HT, Campbell J, Pritchard D, Hien TT, Farrar J, Williams H, Britton J (2006) Poor sanitation and helminth infection protect against skin sensitization in Vietnamese children: a cross-sectional study. J All Clin Immunol 118(6):1305–11
30. Buning J, Homann N, von Smolinski D, Borcherding F, Noack F, Stolte M, Kohl M, Lehnert H, Ludwig D (2008) Helminths as governors of inflammatory bowel disease. Gut 57:1182–1183
31. Broadhurst MJ, Leung JM, Kashyap V, McCune JM, Mahadevan U, McKerrow JH, Loke P (2010) IL-22+ CD4+ T cells are associated with therapeutic trichuris trichiura infection in an ulcerative colitis patient. Sci Trans Med 2:60ra88
32. Pugazhendhi S, Sahu MK, Subramanian V, Pulimood A, Ramakrishna BS (2011) Environmental factors associated with Crohn’s disease in India. Indian J Gastroenterol 30:264–269
33. Fumagalli M, Pozzoli U, Cagliani R, Comi GP, Riva S, Clerici M, Bresolin N, Sironi M (2009) Parasites represent a major selective force for interleukin genes and shape the genetic predisposition to autoimmune conditions. J Exp Med 206:1395–1408
34. Bager P, Vinkel HA, Wohlfahrt J, Melbye M (2012) Helminth infection does not reduce risk for chronic inflammatory disease in a population-based cohort study. Gastroenterology 142:55–62
35. Amre DK, Lambrette P, Law L, Krupoves A, Chotard V, Costea F, Grimard G, Israel D, Mack D, Seidman EG (2006) Investigating the hygiene hypothesis as a risk factor in pediatric onset Crohn’s disease: a case–control study. Am J Gastroenterol 101:1005–1011
36. Weinstock JV, Elliott DE (2014) Helminth infections decrease host susceptibility to immune-mediated diseases. J Immunol 193:3239–3247
37. Hang L, Setiawan T, Blum AM, Urban J, Stoyanoff K, Arihiro S, Reinecker HC, Weinstock JV (2010) Heligmosomoides polygyrus infection can inhibit colitis through direct interaction with innate immunity. J Immunol 185:3184–3189
38. Dragicevic A, Dzopalic T, Vasilijic S, Vucevic D, Tomic S, Bozic B, Colic M (2012) Signaling through Toll-like receptor 3 and Dectin-1 potentiates the capability of human monocyte-derived dendritic cells to promote T-helper 1 and T-helper 17 immune responses. Cytotherapy 14:598–607
39. Dzopalic T, Rajkovic I, Dragicevic A, Colic M (2012) The response of human dendritic cells to co-ligation of pattern-recognition receptors. Immunol Res 52:20–33
40. van Ampting MT, Loonen LM, Schonewille AJ, Konings I, Vink C, Iovanna J, Chamaillard M, Dekker J, van der Meer R, Wells JM, Bovee-Oudenhoven IM (2012) Intestinally secreted C-type lectin Reg3b attenuates salmonellosis but not listeriosis in mice. Inf Immun 80:1115–1120
41. Vaishnava S, Yamamoto M, Severson KM, Ruhn KA, Yu X, Koren O, Ley R, Wakeland EK, Hooper LV (2011) The antibacterial lectin RegIIIgamma promotes the spatial segregation of microbiota and host in the intestine. Science 334:255–258
42. Summers RW, Elliott DE, Urban JF Jr, Thompson R, Weinstock JV (2005) Trichuris suis therapy in Crohn’s disease. Gut 54(1):87–90
43. Summers RW, Elliott DE, Urban JF Jr, Thompson RA, Weinstock JV (2005) Trichuris suis therapy for active ulcerative colitis: a randomized controlled trial. Gastroenterol 128(4):825–32
44. Summers RW, Elliott DE, Weinstock JV (2005) Is there a role for helminths in the therapy of inflammatory bowel disease? Nat Clin Practice Gastroenterol Hep 2:62–63
45. Croese J, O’Neil J, Masson J, Cooke S, Melrose W, Pritchard D, Speare R (2006) A proof of concept study establishing Necator americanus in Crohn’s patients and reservoir donors. Gut 55:136–137